ConductScience.org, home

Paper769679

In vitro studies of cefamandole.

Bodey GP and 1 other. Antimicrob Agents Chemother, 1976. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. In vitro studies of cefamandole. Papers, record 769679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/769679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro studies of cefamandole.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bodey GPG P
2Weaver SS

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
Bacterial InfectionsMajor topic
CephalosporinsMajor topic
Cefoxitin
Cephalexin
Cephalothin
Escherichia coli
Klebsiella pneumoniae
Proteus
Serratia marcescens
Species Specificity
Staphylococcus aureus
Streptococcus

Source PubMed

Download CSV of topics

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14790616Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790616PubMed
24718773Klebsiella bacteremia in cancer patients.Am J Med Sci1973https://conductscience.org/library/papers/4718773PubMed

Download CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
7283419Comparative in vitro study in new cephalosporins.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7283419PubMed
6999021Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.J Clin Microbiol1980https://conductscience.org/library/papers/6999021PubMed
6995096The cephalosporins: activity and clinical use.Drugs1980https://conductscience.org/library/papers/6995096PubMed
3707113Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3707113PubMed
3286537Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial.Int Orthop1988https://conductscience.org/library/papers/3286537PubMed
984809Susceptibility of anaerobic bacteria to 23 antimicrobial agents.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984809PubMed
984808Concentration of cefamandole in serum interstitial fluid, bile, and urine.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984808PubMed
984801Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984801PubMed
671221Pharmacokinetics of cefamandole using a HPLC assay.J Pharmacokinet Biopharm1978https://conductscience.org/library/papers/671221PubMed
426520BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/426520PubMed
413793Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.Infection1977https://conductscience.org/library/papers/413793PubMed
331694In vitro synergy of cefamandole-tobramycin combinations.Yale J Biol Med1977https://conductscience.org/library/papers/331694PubMed
319753Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/319753PubMed
311615Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/311615PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/769679

GET https://conductscience.org/api/papers/v1/769679/authors